Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside.
Sardu C, Massetti M, Scisciola L, Trotta MC, Santamaria M, Volpicelli M, Ducceschi V, Signoriello G, D'Onofrio N, Marfella L, Casolaro F, Amico MD', Ruocco A, Balestrieri ML, Mauro C, Rafaniello C, Capuano A, Paolisso G, Marfella R. Sardu C, et al. Among authors: paolisso g. Pharmacol Res. 2022 Aug;182:106303. doi: 10.1016/j.phrs.2022.106303. Epub 2022 Jun 10. Pharmacol Res. 2022. PMID: 35697289 Free article.
Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate.
Sardu C, Paolisso P, Sacra C, Santamaria M, de Lucia C, Ruocco A, Mauro C, Paolisso G, Rizzo MR, Barbieri M, Marfella R. Sardu C, et al. Among authors: paolisso g, paolisso p. Cardiovasc Diabetol. 2018 Oct 22;17(1):137. doi: 10.1186/s12933-018-0778-9. Cardiovasc Diabetol. 2018. PMID: 30348145 Free PMC article.
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders.
Marfella R, Di Filippo C, Potenza N, Sardu C, Rizzo MR, Siniscalchi M, Musacchio E, Barbieri M, Mauro C, Mosca N, Solimene F, Mottola MT, Russo A, Rossi F, Paolisso G, D'Amico M. Marfella R, et al. Among authors: paolisso g. Eur J Heart Fail. 2013 Nov;15(11):1277-88. doi: 10.1093/eurjhf/hft088. Epub 2013 Jun 4. Eur J Heart Fail. 2013. PMID: 23736534 Free article. Clinical Trial.
Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome.
Sardu C, Santamaria M, Funaro S, Sacra C, Barbieri M, Paolisso P, Marfella R, Paolisso G, Rizzo MR. Sardu C, et al. Among authors: paolisso g, paolisso p. Medicine (Baltimore). 2017 Apr;96(14):e6558. doi: 10.1097/MD.0000000000006558. Medicine (Baltimore). 2017. PMID: 28383431 Free PMC article.
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.
Sardu C, Barbieri M, Santamaria M, Giordano V, Sacra C, Paolisso P, Spirito A, Marfella R, Paolisso G, Rizzo MR. Sardu C, et al. Among authors: paolisso g, paolisso p. Cardiovasc Diabetol. 2017 Jun 9;16(1):75. doi: 10.1186/s12933-017-0554-2. Cardiovasc Diabetol. 2017. PMID: 28599667 Free PMC article. Clinical Trial.
573 results